evidenceId,evidenceType,shortDesc,desc,id,lastEdit,status,gene/entrezGeneId,gene/hugoSymbol,gene/name,gene/oncogene,gene/curatedIsoform,gene/curatedRefSeq,gene/geneAliases/0,gene/geneAliases/1,gene/geneAliases/2,gene/tsg,articles/0/pmid,articles/0/title,articles/0/journal,articles/0/pubDate,articles/0/volume,articles/0/issue,articles/0/pages,articles/0/authors,articles/0/elocationId,articles/0/link,articles/0/reference,articles/0/abstract,articles/1/pmid,articles/1/title,articles/1/journal,articles/1/pubDate,articles/1/volume,articles/1/issue,articles/1/pages,articles/1/authors,articles/1/elocationId,articles/1/link,articles/1/reference,articles/1/abstract,articles/2/pmid,articles/2/title,articles/2/journal,articles/2/pubDate,articles/2/volume,articles/2/issue,articles/2/pages,articles/2/authors,articles/2/elocationId,articles/2/link,articles/2/reference,articles/2/abstract,articles/3/pmid,articles/3/title,articles/3/journal,articles/3/pubDate,articles/3/volume,articles/3/issue,articles/3/pages,articles/3/authors,articles/3/elocationId,articles/3/link,articles/3/reference,articles/3/abstract,articles/4/pmid,articles/4/title,articles/4/journal,articles/4/pubDate,articles/4/volume,articles/4/issue,articles/4/pages,articles/4/authors,articles/4/elocationId,articles/4/link,articles/4/reference,articles/4/abstract,articles/5/pmid,articles/5/title,articles/5/journal,articles/5/pubDate,articles/5/volume,articles/5/issue,articles/5/pages,articles/5/authors,articles/5/elocationId,articles/5/link,articles/5/reference,articles/5/abstract,articles/6/pmid,articles/6/title,articles/6/journal,articles/6/pubDate,articles/6/volume,articles/6/issue,articles/6/pages,articles/6/authors,articles/6/elocationId,articles/6/link,articles/6/reference,articles/6/abstract
18925,GENE_SUMMARY,,"PARK2 encodes a tumor suppressor invovled in tagging cellular proteins for degradation. PARK2 is inactivated in various cancer types, and its dysfunction is associated with hereditary Parkinson's disease.",,2017-01-17,,5071,PARK2,parkin RBR E3 ubiquitin protein ligase,False,ENST00000366898,NM_004562.2,PDJ,LPRS2,AR-JP,False,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
18926,GENE_BACKGROUND,,"PARK2 encodes the parkin protein, which is a component of an E3-ubiquitin ligase complex that serves to mark proteins for proteasomal degradation (PMID: 19946270, 24793136). The PARK2 protein functions by physical interaction with ubiquitin-conjugating enzymes, including UBCH7 and UBCH7 (PMID:19946270). Through regulation of protein stability, PARK2 plays a role in several molecular processes which contribute to oncogenesis, including but not limited to cell cycle progression (PMID:24793136), mitochondrial homeostasis (PMID: 25815004, 24149988) and apoptosis (PMID: 19679562). PARK2 is frequently deleted across a variety of cancer types (PMID: 24793136, 24297497, 19946270); however, other forms of PARK2 inactivation, including somatic mutation and promoter hypermethylation/down-regulation of expression, have also been observed (PMID:24297497 ;cBioPortal,MSKCC, Nov. 2015). Recently, germline mutation in PARK2 has been associated with familial lung cancer (PMID: 25640678).",,2017-01-17,,5071,PARK2,parkin RBR E3 ubiquitin protein ligase,False,ENST00000366898,NM_004562.2,PDJ,LPRS2,AR-JP,False,19679562,Parkin selectively alters the intrinsic threshold for mitochondrial cytochrome c release.,Human molecular genetics,2018-11-15T20:09:00,18,22,4317-28,Berger AK et al,doi: 10.1093/hmg/ddp384,,0001-11-15,,25640678,A recurrent mutation in PARK2 is associated with familial lung cancer.,American journal of human genetics,2018-02-05T20:15:00,96,2,301-8,Xiong D et al,doi: 10.1016/j.ajhg.2014.12.016,,0001-02-05,,24297497,An emerging role of PARK2 in cancer.,"Journal of molecular medicine (Berlin, Germany)",2018-01-01T20:14:00,92,True,31-42,Xu L et al,doi: 10.1007/s00109-013-1107-0,,0001-01-01,,24149988,The accumulation of misfolded proteins in the mitochondrial matrix is sensed by PINK1 to induce PARK2/Parkin-mediated mitophagy of polarized mitochondria.,Autophagy,2018-11-01T20:13:00,9,11,1750-7,Jin SM et al,doi: 10.4161/auto.26122,,0001-11-01,,19946270,Somatic mutations of the Parkinson's disease-associated gene PARK2 in glioblastoma and other human malignancies.,Nature genetics,2018-01-01T20:10:00,42,True,77-82,Veeriah S et al,doi: 10.1038/ng.491,,0001-01-01,,24793136,Pan-cancer genetic analysis identifies PARK2 as a master regulator of G1/S cyclins.,Nature genetics,2018-06-01T20:14:00,46,6,588-94,Gong Y et al,doi: 10.1038/ng.2981,,0001-06-01,,25815004,Mitochondrial dysfunction in Parkinson disease: evidence in mutant PARK2 fibroblasts.,Frontiers in genetics,2015,6,,78,Zanellati MC et al,doi: 10.3389/fgene.2015.00078,,Zanellati MC et al. Frontiers in genetics. 2015;6()78.,
